𝔖 Bobbio Scriptorium

✦ LIBER ✦

Dosimetry in support of patient protection in diagnostic radiology - a valedictory view from the UK

✍ Scribed by Shrimpton, Paul C.

Book ID: 126992658
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 60 KB
Volume: 30
Category: Article
ISSN: 1120-1797
DOI: 10.1016/j.ejmp.2014.07.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Revised radiation doses for typical X-ra

Revised radiation doses for typical X-ray examinations. Report on a recent review of doses to patients from medical X-ray examinations in the UK by NRPB. National Radiological Protection Board.

✍ Wall, B F; Hart, D 📂 Article 📅 1997 🏛 British Institute of Radiology 🌐 English ⚖ 213 KB

Quality control and radiation protection

Quality control and radiation protection of the patient in diagnostic radiology and nuclear medicine: Edited by G. Contento, B. Wall, H. Schibilla and D. Teunen. Nuclear Technology Publishing, Ashford, Kent, U.K. ISBN 1 870965 37 X, Hardback, 512 pp. Price £90.00 (Published as Radiation Protection Dosimetry, Vol. 57(1–4), 1995—free to journal subscribers).

✍ David M. Taylor 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Results of a pilot randomised controlled

Results of a pilot randomised controlled trial to measure the clinical and cost effectiveness of peer support in increasing hope and quality of life in mental health patients discharged from hospital in the UK

✍ Simpson, Alan; Flood, Chris; Rowe, Julie; Quigley, Jody; Henry, Susan; Hall, Cer 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 397 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Effect of comorbidity on risk of venous

Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma11The project described was supported by the National Center for Research Resources, United States, through Grant KL2TR000084 the National Center for Advancing Translational Sciences, United States, through Grant KL2TR000084 and the National Institutes of Health, United States, through Grant KL2TR000084, and a grant from the Danish Cancer Society (R73-A4284-13-S17) and from the Karen Elise Jensen Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH and the Clinical Epidemiological Research Foundation.

✍ Smith, Angela B.; Horvath-Puhó, Erzsébet; Nielsen, Matthew E.; Lash, Timothy L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Committee reports. Report on patent law

Committee reports. Report on patent law revision**The evidence in support of the Preambles and Resolutions and suggested additions to the copyright, patent and trade-mark laws contained in the first part of our report was not published in the May Journal owing to want of space. I am now sending you the remaining part of the report, by request, as it is considered quite necessary for the members of the Association to have in their hands before the next annual meeting, the entire document for consideration and study. It is believed that this will decidedly facilitate matters and save much time at the annual meeting which otherwise might be used up in unnecessary discussion of the subject.Your Committee wishes to again emphasize that fact that we have no desire to impose our personal views on the Association. The copyright and patent laws were designed to promote progress in science and the useful arts and the trade-mark laws to protect the public from fraud and imposition. It is generally conceded that the laws as now interpreted and applied fall short in accomplishing their purpose. It is therefore incumbent upon the A. Ph. A., representing the pharmacists of America, to suggest proper modifications of the law, of such kind as to secure the very important objects for which they were enacted.—F. E. Stewarcth, Chairman.

📂 Article 📅 1917 🏛 Elsevier ⚖ 359 KB 👁 2 views